INJECTION DEPOT MEDROXY PROGESTERENE ACETATE (DMPA): OUR EXPERIENCE AT TERTIARY CARE TEACHING HOSPITAL
DOI:
https://doi.org/10.48047/Keywords:
DMPA, postpartum contraception, family planning,Abstract
Background: Injectable Contraceptive is fourth most popular family planning method worldwide after female sterilization, intra uterine contraceptive device & oral contraceptive. Postpartum contraception is crucial for health of women. Method: This was retrospective study from 1 st Jan 2020 to 31st August 2021 at tertiary care teaching hospital in pune Aim of study was to know demographic details of DMPA (Depot Metroxy Progesterone Acetate) users, side effects & compliance of Inj DMPA. Medical record of 223 women who opted for Inj DMPA after counseling regarding contraceptive options was studied.
Results: Most common side effect observed in Inj DMPA users was menstrual disorder irregular bleeding 62.3% followed by weight gain, amenorrhea & headache in 9.4%,1.7% & 1.3% women respectively. 24.66% women were para one while majority of DMPA users
belonged to 21 to 25 years of age group. Conclusion: MPA is highly effective, safe, long term reversible contraceptive option. Proper counseling if done before & after administration of Inj DMPA lead to better patient compliance.
